100 related articles for article (PubMed ID: 34530993)
1. Influence of Caspase-9 polymorphisms on the development of Chronic Myeloid Leukemia- A case-control study.
Edathara PM; Gorre M; Kagita S; Cingeetham A; Annamaneni S; Digumarti R; Satti V
Gene; 2019; 721S():100002. PubMed ID: 34530993
[TBL] [Abstract][Full Text] [Related]
2. Association of caspase9 promoter polymorphisms with the susceptibility of AML in south Indian subjects.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Mekkaw P; Annamaneni S; Digumarthi RR; Sinha S; Satti V
Tumour Biol; 2014 Sep; 35(9):8813-22. PubMed ID: 24879622
[TBL] [Abstract][Full Text] [Related]
3. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
[TBL] [Abstract][Full Text] [Related]
4. Association of promoter polymorphisms of Fas -FasL genes with development of Chronic Myeloid Leukemia.
Edathara PM; Gorre M; Kagita S; Vuree S; Cingeetham A; Nanchari SR; Meka PB; Annamaneni S; Digumarthi RR; Satti V
Tumour Biol; 2016 Apr; 37(4):5475-84. PubMed ID: 26563376
[TBL] [Abstract][Full Text] [Related]
5. A controlled case study of the relationship between environmental risk factors and apoptotic gene polymorphism and lumbar disc herniation.
Zhang YG; Zhang F; Sun Z; Guo W; Liu J; Liu M; Guo X
Am J Pathol; 2013 Jan; 182(1):56-63. PubMed ID: 23141929
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms and haplotypes in caspases 8 and 9 genes and risk for prostate cancer: a case-control study in cohort of North India.
George GP; Mandal RK; Kesarwani P; Sankhwar SN; Mandhani A; Mittal RD
Urol Oncol; 2012; 30(6):781-9. PubMed ID: 21396853
[TBL] [Abstract][Full Text] [Related]
7. Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population.
Gangwar R; Mandhani A; Mittal RD
Ann Surg Oncol; 2009 Jul; 16(7):2028-34. PubMed ID: 19412632
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma.
Lan Q; Zheng T; Chanock S; Zhang Y; Shen M; Wang SS; Berndt SI; Zahm SH; Holford TR; Leaderer B; Yeager M; Welch R; Hosgood D; Boyle P; Rothman N
Carcinogenesis; 2007 Apr; 28(4):823-7. PubMed ID: 17071630
[TBL] [Abstract][Full Text] [Related]
9. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
[TBL] [Abstract][Full Text] [Related]
10. Association between Caspase-9 promoter region polymorphisms and discogenic low back pain.
Guo TM; Liu M; Zhang YG; Guo WT; Wu SX
Connect Tissue Res; 2011 Apr; 52(2):133-8. PubMed ID: 21091209
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and Functional Importance of Selected CASP8 and CASP9 Polymorphisms in Breast Carcinoma].
Brynychová V; Václavíková R; Kubáčková K; Mrhalová M; Kodet R; Rauš K; Vrána D; Gatěk J; Bendová M; Souček P
Klin Onkol; 2016; 29(6):445-453. PubMed ID: 27951722
[TBL] [Abstract][Full Text] [Related]
12. CASP9 (caspase 9) is essential for autophagosome maturation through regulation of mitochondrial homeostasis.
An HK; Chung KM; Park H; Hong J; Gim JE; Choi H; Lee YW; Choi J; Mun JY; Yu SW
Autophagy; 2020 Sep; 16(9):1598-1617. PubMed ID: 31818185
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia.
Bruzzoni-Giovanelli H; González JR; Sigaux F; Villoutreix BO; Cayuela JM; Guilhot J; Preudhomme C; Guilhot F; Poyet JL; Rousselot P
Oncotarget; 2015 Nov; 6(34):36269-77. PubMed ID: 26474455
[TBL] [Abstract][Full Text] [Related]
14. The Role of Caspase Genes Polymorphisms in Genetic Susceptibility to Philadelphia-Negative Myeloproliferative Neoplasms in a Portuguese Population.
Azevedo AP; Silva SN; Reichert A; Lima F; Júnior E; Rueff J
Pathol Oncol Res; 2019 Jul; 25(3):961-969. PubMed ID: 29542026
[TBL] [Abstract][Full Text] [Related]
15. CASP9 c.-1339A>G and CASP3 c.-1191A>G polymorphisms alter susceptibility and clinical aspects of head and neck squamous cell carcinoma.
Costa EFD; Lopes-Aguiar L; Nogueira GS; Lima TRP; Rinck-Junior JA; Lourenço GJ; Lima CSP
Head Neck; 2019 Aug; 41(8):2665-2670. PubMed ID: 30903678
[TBL] [Abstract][Full Text] [Related]
16. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
Lou Y; Fang CQ; Li JH
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
[TBL] [Abstract][Full Text] [Related]
17. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
[TBL] [Abstract][Full Text] [Related]
18. Two novel single-nucleotide polymorphisms of the Caspase-9 (CASP9) gene in the Japanese population.
Hirano A; Nagai H; Harada H; Haga S; Kajiwara T; Emi M
Genes Immun; 2001 Apr; 2(2):117-8. PubMed ID: 11393657
[TBL] [Abstract][Full Text] [Related]
19. Significance of ATM Gene Polymorphisms in Chronic Myeloid Leukemia - a Case Control Study from India.
Gorre M; Mohandas PE; Kagita S; Cingeetham A; Vuree S; Jarjapu S; Nanchari S; Meka PB; Annamaneni S; Dunna NR; Digumarti R; Satti V
Asian Pac J Cancer Prev; 2016; 17(2):815-21. PubMed ID: 26925685
[TBL] [Abstract][Full Text] [Related]
20. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
